Plasma exchange therapy for steroid-refractory superimposed relapses in secondary progressive multiple sclerosis [5]

Journal of Neurology

Volumn 254, Issue 9, 2007, Pages 1288-1289

  Linker, Ralf A ^a   Chan, Andrew ^a   Sommer, Martin ^a   Koziolek, Michael ^a   Müller, Gerhard Anton ^a   Paulus, Walter ^a   Gold, Ralf ^a,b  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b ST JOSEF HOSPITAL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; GLATIRAMER; MEPREDNISONE; MITOXANTRONE;

ADULT; CASE REPORT; CEREBROSPINAL FLUID; DISEASE COURSE; FEMALE; HUMAN; LETTER; MULTIPLE SCLEROSIS; PARAPLEGIA; PLASMAPHERESIS; PRIORITY JOURNAL; QUADRIPLEGIA; RELAPSE; WALKING DIFFICULTY;

ANTINEOPLASTIC AGENTS; DRUG RESISTANCE; FEMALE; HUMANS; MIDDLE AGED; MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE; PLASMA EXCHANGE; RECURRENCE; STEROIDS; TREATMENT OUTCOME;

EID: 36148987620     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-006-0497-0     Document Type: Letter

References (10)

1. Weinshenker BG, O'Brien PC, Petterson TM, Noseworthy JH, Lucchinetti CF, Dodick DW, Pineda AA, Stevens LN, Rodriguez M (1999) A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease. Ann Neurol 46(6):878-886
2. Ruprecht K, Klinker E, Dintelmann T, Rieckmann P, Gold R (2004) Plasma exchange for severe optic neuritis: treatment of 10 patients. Neurology 63(6):1081-1083
3. Schilling S, Linker RA, Konig FB, Koziolek M, Bahr M, Muller GA, Paulus W, Gartner J, Bruck W, Chan A, Gold R (2006) Plasma exchange therapy for steroid-unresponsive multiple sclerosis relapses: clinical experience with 16 patients. Nervenarzt 77(4):430-438
4. Keegan M, Konig F, McClelland R, Bruck W, Morales Y, Bitsch A, Panitch H, Lassmann H, Weinshenker B, Rodriguez M, Parisi J, Lucchinetti CF (2005) Relation between humoral pathological changes in multiple sclerosis and response to therapeutic plasma exchange. Lancet 366(9485):579-582
5. Keegan M, Pineda AA, McClelland RL, Darby CH, Rodriguez M, Weinshenker BG (2002) Plasma exchange for severe attacks of CNS demyelination: predictors of response. Neurology 58(1):143-146
6. Lucchinetti C, Bruck W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H (2000) Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol 47(6):707-717
7. Pittock SJ, McClelland RL, Achenbach SJ, Konig F, Bitsch A, Bruck W, Lassmann H, Parisi JE, Scheithauer BW, Rodriguez M, Weinshenker BG, Lucchinetti CF (2005) Clinical course, pathological correlations, and outcome of biopsy proved inflammatory demyelinating disease. J Neurol Neurosurg Psychiatry 76(12):1693-1697
8. The Canadian Cooperative Multiple Sclerosis Study Group (1991) The Canadian cooperative trial of cyclophosphamide and plasma exchange in progressive multiple sclerosis. Lancet 337(8739):441-446
9. Khatri BO, McQuillen MP, Harrington GJ, Schmoll D, Hoffmann RG (1985) Chronic progressive multiple sclerosis: double-blind controlled study of plasmapheresis in patients taking immunosuppressive drugs. Neurology 35(3):312-319
10. Sorensen PS, Wanscher B, Szpirt W, Jensen CV, Ravnborg M, Christiansen P, Schreiber K, Nordenbo A (1996) Plasma exchange combined with azathioprine in multiple sclerosis using serial gadolinium-enhanced MRI to monitor disease activity: a randomized single-masked cross-over pilot study. Neurology 46(6):1620-1625